Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 268 entries
Sorted by: Best Match Show Resources per page
Multimodal approach in the pre-surgical evaluation of focal epilepsy surgery candidates: how far are we from a non-invasive ESI-based "sourcectomy"?.

Epileptic disorders : international epilepsy journal with videotape

Nobile G, Consales A, Tortora D, Pacetti M, Gianno F, Arnaldi D, Morbelli S, Mancardi M, Sartori I, Cossu M, Nobili L, Cataldi M.
PMID: 34279233
Epileptic Disord. 2021 Aug 01;23(4):661-666. doi: 10.1684/epd.2021.1309.

The management of drug-resistant patients with focal epilepsy is often challenging. Surgery is recognised as a useful and effective treatment option. The identification of the epileptogenic zone relies on the integration of clinical, neurophysiological, and neuroimaging findings. The role...

Cite
Nobile G, Consales A, Tortora D, et al. Multimodal approach in the pre-surgical evaluation of focal epilepsy surgery candidates: how far are we from a non-invasive ESI-based "sourcectomy"?. Epileptic Disord. 2021;23(4):661-666doi: 10.1684/epd.2021.1309.
Nobile, G., Consales, A., Tortora, D., Pacetti, M., Gianno, F., Arnaldi, D., Morbelli, S., Mancardi, M., Sartori, I., Cossu, M., Nobili, L., & Cataldi, M. (2021). Multimodal approach in the pre-surgical evaluation of focal epilepsy surgery candidates: how far are we from a non-invasive ESI-based "sourcectomy"?. Epileptic disorders : international epilepsy journal with videotape, 23(4), 661-666. https://doi.org/10.1684/epd.2021.1309
Nobile, Giulia, et al. "Multimodal approach in the pre-surgical evaluation of focal epilepsy surgery candidates: how far are we from a non-invasive ESI-based "sourcectomy"?." Epileptic disorders : international epilepsy journal with videotape vol. 23,4 (2021): 661-666. doi: https://doi.org/10.1684/epd.2021.1309
Nobile G, Consales A, Tortora D, Pacetti M, Gianno F, Arnaldi D, Morbelli S, Mancardi M, Sartori I, Cossu M, Nobili L, Cataldi M. Multimodal approach in the pre-surgical evaluation of focal epilepsy surgery candidates: how far are we from a non-invasive ESI-based "sourcectomy"?. Epileptic Disord. 2021 Aug 01;23(4):661-666. doi: 10.1684/epd.2021.1309. PMID: 34279233.
Copy Download .nbib Format: NLM
Epileptic Capgras-Like Delusions in a Patient with Right Frontal Meningioma: Case Report.

Case reports in neurology

Colombo E, Messina S, Verde F, Locatelli M, Poletti B, Silani V, Ticozzi N.
PMID: 34177534
Case Rep Neurol. 2021 May 27;13(2):284-288. doi: 10.1159/000513675. eCollection 2021.

Capgras syndrome is a condition characterized by the belief that a relative has been replaced by an almost identical imposter. The disorder has been reported in several neurological diseases. We describe the uncommon case of a transient Capgras syndrome...

Cite
Colombo E, Messina S, Verde F, et al. Epileptic Capgras-Like Delusions in a Patient with Right Frontal Meningioma: Case Report. Case Rep Neurol. 2021;13(2):284-288doi: 10.1159/000513675.
Colombo, E., Messina, S., Verde, F., Locatelli, M., Poletti, B., Silani, V., & Ticozzi, N. (2021). Epileptic Capgras-Like Delusions in a Patient with Right Frontal Meningioma: Case Report. Case reports in neurology, 13(2), 284-288. https://doi.org/10.1159/000513675
Colombo, Eleonora, et al. "Epileptic Capgras-Like Delusions in a Patient with Right Frontal Meningioma: Case Report." Case reports in neurology vol. 13,2 (2021): 284-288. doi: https://doi.org/10.1159/000513675
Colombo E, Messina S, Verde F, Locatelli M, Poletti B, Silani V, Ticozzi N. Epileptic Capgras-Like Delusions in a Patient with Right Frontal Meningioma: Case Report. Case Rep Neurol. 2021 May 27;13(2):284-288. doi: 10.1159/000513675. eCollection 2021. PMID: 34177534; PMCID: PMC8215999.
Copy Download .nbib Format: NLM
Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response.

Early intervention in psychiatry

Scazza I, Pelizza L, Azzali S, Garlassi S, Paterlini F, Chiri LR, Poletti M, Pupo S, Raballo A.
PMID: 34786863
Early Interv Psychiatry. 2021 Nov 16; doi: 10.1111/eip.13243. Epub 2021 Nov 16.

AIM: Aberrant salience (AS) is considered a putative predisposing factor for the onset of psychosis. However, despite several studies conducted in the general population, research in early psychosis is still relatively scarce. The main purposes of this study were...

Cite
Scazza I, Pelizza L, Azzali S, et al. Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response. Early Interv Psychiatry. 2021;doi: 10.1111/eip.13243.
Scazza, I., Pelizza, L., Azzali, S., Garlassi, S., Paterlini, F., Chiri, L. R., Poletti, M., Pupo, S., & Raballo, A. (2021). Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response. Early intervention in psychiatry, . https://doi.org/10.1111/eip.13243
Scazza, Ilaria, et al. "Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response." Early intervention in psychiatry vol. (2021). doi: https://doi.org/10.1111/eip.13243
Scazza I, Pelizza L, Azzali S, Garlassi S, Paterlini F, Chiri LR, Poletti M, Pupo S, Raballo A. Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response. Early Interv Psychiatry. 2021 Nov 16; doi: 10.1111/eip.13243. Epub 2021 Nov 16. PMID: 34786863.
Copy Download .nbib Format: NLM
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography.

Frontiers in bioscience (Landmark edition)

Baratella E, Roman-Pognuz E, Zerbato V, Minelli P, Cavallaro MFM, Cova MA, Luzzati R, Lucangelo U, Sanson G, Friso F, Bussani R, Pinamonti M, Busetti M, Salton F, Confalonieri M, Ruaro B, Di Bella S, Haugen T, Aasen TM.
PMID: 34994174
Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1607-1612. doi: 10.52586/5053.

PURPOSE: The aim of this observational study was to highlight high resolution CT scan characteristics of COVID-19-associated pulmonary aspergillosis (CAPA) with a focus on the detection of de-novo appeared or evolved bronchiectasis.METHODS: From March 2020 to May 2021, we...

Cite
Baratella E, Roman-Pognuz E, Zerbato V, et al. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography. Front Biosci (Landmark Ed). 2021;26(12):1607-1612doi: 10.52586/5053.
Baratella, E., Roman-Pognuz, E., Zerbato, V., Minelli, P., Cavallaro, M. F. M., Cova, M. A., Luzzati, R., Lucangelo, U., Sanson, G., Friso, F., Bussani, R., Pinamonti, M., Busetti, M., Salton, F., Confalonieri, M., Ruaro, B., Di Bella, S., Haugen, T., & Aasen, T. M. (2021). Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography. Frontiers in bioscience (Landmark edition), 26(12), 1607-1612. https://doi.org/10.52586/5053
Baratella, Elisa, et al. "Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography." Frontiers in bioscience (Landmark edition) vol. 26,12 (2021): 1607-1612. doi: https://doi.org/10.52586/5053
Baratella E, Roman-Pognuz E, Zerbato V, Minelli P, Cavallaro MFM, Cova MA, Luzzati R, Lucangelo U, Sanson G, Friso F, Bussani R, Pinamonti M, Busetti M, Salton F, Confalonieri M, Ruaro B, Di Bella S, Haugen T, Aasen TM. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography. Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1607-1612. doi: 10.52586/5053. PMID: 34994174.
Copy Download .nbib Format: NLM
Attachment, Personality and Locus of Control: Psychological Determinants of Risk Perception and Preventive Behaviors for COVID-19.

Frontiers in psychology

Tagini S, Brugnera A, Ferrucci R, Mazzocco K, Pievani L, Priori A, Ticozzi N, Compare A, Silani V, Pravettoni G, Poletti B.
PMID: 34305708
Front Psychol. 2021 Jul 09;12:634012. doi: 10.3389/fpsyg.2021.634012. eCollection 2021.

No abstract available.

Cite
Tagini S, Brugnera A, Ferrucci R, et al. Attachment, Personality and Locus of Control: Psychological Determinants of Risk Perception and Preventive Behaviors for COVID-19. Front Psychol. 2021;12:634012doi: 10.3389/fpsyg.2021.634012.
Tagini, S., Brugnera, A., Ferrucci, R., Mazzocco, K., Pievani, L., Priori, A., Ticozzi, N., Compare, A., Silani, V., Pravettoni, G., & Poletti, B. (2021). Attachment, Personality and Locus of Control: Psychological Determinants of Risk Perception and Preventive Behaviors for COVID-19. Frontiers in psychology, 12634012. https://doi.org/10.3389/fpsyg.2021.634012
Tagini, Sofia, et al. "Attachment, Personality and Locus of Control: Psychological Determinants of Risk Perception and Preventive Behaviors for COVID-19." Frontiers in psychology vol. 12 (2021): 634012. doi: https://doi.org/10.3389/fpsyg.2021.634012
Tagini S, Brugnera A, Ferrucci R, Mazzocco K, Pievani L, Priori A, Ticozzi N, Compare A, Silani V, Pravettoni G, Poletti B. Attachment, Personality and Locus of Control: Psychological Determinants of Risk Perception and Preventive Behaviors for COVID-19. Front Psychol. 2021 Jul 09;12:634012. doi: 10.3389/fpsyg.2021.634012. eCollection 2021. PMID: 34305708; PMCID: PMC8299752.
Copy Download .nbib Format: NLM
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.

JAMA oncology

Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley CJ, Owen DH, Abou Alaiwi S, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman TA, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Dal Bello MG, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Choueiri TK, Johnson DB, Marron TU, Wang Y, Naqash AR.
PMID: 34734989
JAMA Oncol. 2021 Nov 04; doi: 10.1001/jamaoncol.2021.4960. Epub 2021 Nov 04.

IMPORTANCE: Geriatric (aged ≥80 years) patients are historically underrepresented in cancer clinical trials. Little is known about the efficacy of immune checkpoint inhibitors (ICIs) in geriatric patients. These agents are associated with immune-related adverse events (irAEs), which may be...

Cite
Nebhan CA, Cortellini A, Ma W, et al. Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. JAMA Oncol. 2021;doi: 10.1001/jamaoncol.2021.4960.
Nebhan, C. A., Cortellini, A., Ma, W., Ganta, T., Song, H., Ye, F., Irlmeier, R., Debnath, N., Saeed, A., Radford, M., Alahmadi, A., Diamond, A., Hoimes, C., Ramaiya, N., Presley, C. J., Owen, D. H., Abou Alaiwi, S., Nassar, A., Ricciuti, B., Lamberti, G., Bersanelli, M., Casartelli, C., Buti, S., Marchetti, P., Giusti, R., Filetti, M., Vanella, V., Mallardo, D., Macherla, S., Sussman, T. A., Botticelli, A., Galetta, D., Catino, A., Pizzutilo, P., Genova, C., Dal Bello, M. G., Kalofonou, F., Daniels, E., Ascierto, P. A., Pinato, D. J., Choueiri, T. K., Johnson, D. B., Marron, T. U., Wang, Y., & Naqash, A. R. (2021). Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. JAMA oncology, . https://doi.org/10.1001/jamaoncol.2021.4960
Nebhan, Caroline A, et al. "Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study." JAMA oncology vol. (2021). doi: https://doi.org/10.1001/jamaoncol.2021.4960
Nebhan CA, Cortellini A, Ma W, Ganta T, Song H, Ye F, Irlmeier R, Debnath N, Saeed A, Radford M, Alahmadi A, Diamond A, Hoimes C, Ramaiya N, Presley CJ, Owen DH, Abou Alaiwi S, Nassar A, Ricciuti B, Lamberti G, Bersanelli M, Casartelli C, Buti S, Marchetti P, Giusti R, Filetti M, Vanella V, Mallardo D, Macherla S, Sussman TA, Botticelli A, Galetta D, Catino A, Pizzutilo P, Genova C, Dal Bello MG, Kalofonou F, Daniels E, Ascierto PA, Pinato DJ, Choueiri TK, Johnson DB, Marron TU, Wang Y, Naqash AR. Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study. JAMA Oncol. 2021 Nov 04; doi: 10.1001/jamaoncol.2021.4960. Epub 2021 Nov 04. PMID: 34734989; PMCID: PMC8569601.
Copy Download .nbib Format: NLM
Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?.

The international journal of neuropsychopharmacology

Raballo A, Poletti M, Preti A.
PMID: 34036323
Int J Neuropsychopharmacol. 2021 Sep 21;24(9):710-720. doi: 10.1093/ijnp/pyab030.

INTRODUCTION: Sample enrichment is a key factor in contemporary early-detection strategies aimed at the identification of help-seekers at increased risk of imminent transition to psychosis. We undertook a meta-analytic investigation to ascertain the role of sample enrichment in the...

Cite
Raballo A, Poletti M, Preti A. Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?. Int J Neuropsychopharmacol. 2021;24(9):710-720doi: 10.1093/ijnp/pyab030.
Raballo, A., Poletti, M., & Preti, A. (2021). Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?. The international journal of neuropsychopharmacology, 24(9), 710-720. https://doi.org/10.1093/ijnp/pyab030
Raballo, Andrea, et al. "Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?." The international journal of neuropsychopharmacology vol. 24,9 (2021): 710-720. doi: https://doi.org/10.1093/ijnp/pyab030
Raballo A, Poletti M, Preti A. Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?. Int J Neuropsychopharmacol. 2021 Sep 21;24(9):710-720. doi: 10.1093/ijnp/pyab030. PMID: 34036323; PMCID: PMC8453273.
Copy Download .nbib Format: NLM
The experience of social distancing for families with children and adolescents during the coronavirus (COVID-19) pandemic in Uruguay: Difficulties and opportunities.

Children and youth services review

Ares G, Bove I, Vidal L, Brunet G, Fuletti D, Arroyo Á, Blanc MV.
PMID: 33390638
Child Youth Serv Rev. 2021 Feb;121:105906. doi: 10.1016/j.childyouth.2020.105906. Epub 2020 Dec 29.

The social distancing measures implemented to contain the coronavirus (COVID-19) pandemic worldwide have created a series of emotional and economic challenges. The aim of the present work was to explore the experiences of families with children and adolescents during...

Cite
Ares G, Bove I, Vidal L, et al. The experience of social distancing for families with children and adolescents during the coronavirus (COVID-19) pandemic in Uruguay: Difficulties and opportunities. Child Youth Serv Rev. 2020;121:105906doi: 10.1016/j.childyouth.2020.105906.
Ares, G., Bove, I., Vidal, L., Brunet, G., Fuletti, D., Arroyo, �. �., & Blanc, M. V. (2021). The experience of social distancing for families with children and adolescents during the coronavirus (COVID-19) pandemic in Uruguay: Difficulties and opportunities. Children and youth services review, 121105906. https://doi.org/10.1016/j.childyouth.2020.105906
Ares, Gastón, et al. "The experience of social distancing for families with children and adolescents during the coronavirus (COVID-19) pandemic in Uruguay: Difficulties and opportunities." Children and youth services review vol. 121 (2021): 105906. doi: https://doi.org/10.1016/j.childyouth.2020.105906
Ares G, Bove I, Vidal L, Brunet G, Fuletti D, Arroyo Á, Blanc MV. The experience of social distancing for families with children and adolescents during the coronavirus (COVID-19) pandemic in Uruguay: Difficulties and opportunities. Child Youth Serv Rev. 2021 Feb;121:105906. doi: 10.1016/j.childyouth.2020.105906. Epub 2020 Dec 29. PMID: 33390638; PMCID: PMC7771899.
Copy Download .nbib Format: NLM
Evaluation of lignan-loaded poly(ε-caprolactone) nanoparticles: synthesis, characterization, .

Natural product research

Lima TC, Magalhães LG, Paula LAL, Cunha WR, Januário AH, Pauletti PM, Bastos JK, Dos Santos FF, Forim MR, Laurentiz RS, Santos FA, Orenha RP, Parreira RLT, Fuzo CA, Molina EF, Santos MFC, Silva MLAE.
PMID: 34963393
Nat Prod Res. 2021 Dec 29;1-7. doi: 10.1080/14786419.2021.2021515. Epub 2021 Dec 29.

Lignan dinitrohinokinin displays important biological activities, which led to the preparation of its poly-ε-caprolactone nanoparticles. Kinetics analysis revealed initially slow drug release followed by a prolonged, moderate release 6 h later due to DNHK diffusion through the polymeric matrix....

Cite
Lima TC, Magalhães LG, Paula LAL, et al. Evaluation of lignan-loaded poly(ε-caprolactone) nanoparticles: synthesis, characterization, . Nat Prod Res. 2021;1-7doi: 10.1080/14786419.2021.2021515.
Lima, T. C., Magalhães, L. G., Paula, L. A. L., Cunha, W. R., Januário, A. H., Pauletti, P. M., Bastos, J. K., Dos Santos, F. F., Forim, M. R., Laurentiz, R. S., Santos, F. A., Orenha, R. P., Parreira, R. L. T., Fuzo, C. A., Molina, E. F., Santos, M. F. C., & Silva, M. L. A. E. (2021). Evaluation of lignan-loaded poly(ε-caprolactone) nanoparticles: synthesis, characterization, . Natural product research, 1-7. https://doi.org/10.1080/14786419.2021.2021515
Lima, Thais C, et al. "Evaluation of lignan-loaded poly(ε-caprolactone) nanoparticles: synthesis, characterization, ." Natural product research vol. (2021): 1-7. doi: https://doi.org/10.1080/14786419.2021.2021515
Lima TC, Magalhães LG, Paula LAL, Cunha WR, Januário AH, Pauletti PM, Bastos JK, Dos Santos FF, Forim MR, Laurentiz RS, Santos FA, Orenha RP, Parreira RLT, Fuzo CA, Molina EF, Santos MFC, Silva MLAE. Evaluation of lignan-loaded poly(ε-caprolactone) nanoparticles: synthesis, characterization, . Nat Prod Res. 2021 Dec 29;1-7. doi: 10.1080/14786419.2021.2021515. Epub 2021 Dec 29. PMID: 34963393.
Copy Download .nbib Format: NLM
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.

Cancers

Duranti S, Fabi A, Filetti M, Falcone R, Lombardi P, Daniele G, Franceschini G, Carbognin L, Palazzo A, Garganese G, Paris I, Scambia G, Pietragalla A.
PMID: 34680350
Cancers (Basel). 2021 Oct 16;13(20). doi: 10.3390/cancers13205198.

Breast cancer represents the first cause of cancer worldwide and the leading cause of cancer mortality for women. Therefore, new therapies are needed to improve the prognosis of women diagnosed with this disease. In this review, we summarize the...

Cite
Duranti S, Fabi A, Filetti M, et al. Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers (Basel). 2021;13(20)doi: 10.3390/cancers13205198.
Duranti, S., Fabi, A., Filetti, M., Falcone, R., Lombardi, P., Daniele, G., Franceschini, G., Carbognin, L., Palazzo, A., Garganese, G., Paris, I., Scambia, G., & Pietragalla, A. (2021). Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers, 13(20), . https://doi.org/10.3390/cancers13205198
Duranti, Simona, et al. "Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials." Cancers vol. 13,20 (2021). doi: https://doi.org/10.3390/cancers13205198
Duranti S, Fabi A, Filetti M, Falcone R, Lombardi P, Daniele G, Franceschini G, Carbognin L, Palazzo A, Garganese G, Paris I, Scambia G, Pietragalla A. Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers (Basel). 2021 Oct 16;13(20). doi: 10.3390/cancers13205198. PMID: 34680350; PMCID: PMC8533780.
Copy Download .nbib Format: NLM
Unprotected Galactosamine as a Dynamic Key for a Cyclochiral Lock.

Journal of the American Society for Mass Spectrometry

Fraschetti C, Letzel MC, Paletta M, Mattay J, Crestoni ME, Chiavarino B, Filippi A.
PMID: 33499589
J Am Soc Mass Spectrom. 2021 Mar 03;32(3):736-743. doi: 10.1021/jasms.0c00437. Epub 2021 Jan 26.

The discrimination of d-galactosamine (

Cite
Fraschetti C, Letzel MC, Paletta M, et al. Unprotected Galactosamine as a Dynamic Key for a Cyclochiral Lock. J Am Soc Mass Spectrom. 2021;32(3):736-743doi: 10.1021/jasms.0c00437.
Fraschetti, C., Letzel, M. C., Paletta, M., Mattay, J., Crestoni, M. E., Chiavarino, B., & Filippi, A. (2021). Unprotected Galactosamine as a Dynamic Key for a Cyclochiral Lock. Journal of the American Society for Mass Spectrometry, 32(3), 736-743. https://doi.org/10.1021/jasms.0c00437
Fraschetti, Caterina, et al. "Unprotected Galactosamine as a Dynamic Key for a Cyclochiral Lock." Journal of the American Society for Mass Spectrometry vol. 32,3 (2021): 736-743. doi: https://doi.org/10.1021/jasms.0c00437
Fraschetti C, Letzel MC, Paletta M, Mattay J, Crestoni ME, Chiavarino B, Filippi A. Unprotected Galactosamine as a Dynamic Key for a Cyclochiral Lock. J Am Soc Mass Spectrom. 2021 Mar 03;32(3):736-743. doi: 10.1021/jasms.0c00437. Epub 2021 Jan 26. PMID: 33499589; PMCID: PMC7944569.
Copy Download .nbib Format: NLM
A Novel Mutation of .

Frontiers in neurology

Ciammola A, Sangalli D, Sassone J, Poletti B, Carelli L, Banfi P, Pappacoda G, Ceccherini I, Grossi A, Maderna L, Pingue M, Girotti F, Silani V.
PMID: 31781017
Front Neurol. 2019 Nov 06;10:1124. doi: 10.3389/fneur.2019.01124. eCollection 2019.

Alexander disease (AxD) is a rare, autosomal dominant neurological disorder. Three clinical subtypes are distinguished based on age at onset: infantile (0-2 years), juvenile (2-13 years), and adult (>13 years). The three forms differ in symptoms and prognosis. Rapid...

Cite
Ciammola A, Sangalli D, Sassone J, et al. A Novel Mutation of . Front Neurol. 2019;10:1124doi: 10.3389/fneur.2019.01124.
Ciammola, A., Sangalli, D., Sassone, J., Poletti, B., Carelli, L., Banfi, P., Pappacoda, G., Ceccherini, I., Grossi, A., Maderna, L., Pingue, M., Girotti, F., & Silani, V. (2019). A Novel Mutation of . Frontiers in neurology, 101124. https://doi.org/10.3389/fneur.2019.01124
Ciammola, Andrea, et al. "A Novel Mutation of ." Frontiers in neurology vol. 10 (2019): 1124. doi: https://doi.org/10.3389/fneur.2019.01124
Ciammola A, Sangalli D, Sassone J, Poletti B, Carelli L, Banfi P, Pappacoda G, Ceccherini I, Grossi A, Maderna L, Pingue M, Girotti F, Silani V. A Novel Mutation of . Front Neurol. 2019 Nov 06;10:1124. doi: 10.3389/fneur.2019.01124. eCollection 2019. PMID: 31781017; PMCID: PMC6851058.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 268 entries